These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32500804)

  • 21. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.
    Ignjatović Ristić D; Cohen D; Obradović A; Nikić-Đuričić K; Drašković M; Hinić D
    Nord J Psychiatry; 2018 Feb; 72(2):124-129. PubMed ID: 29125018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.
    Wichniak A; Skowerska A; Chojnacka-Wójtowicz J; Tafliński T; Wierzbicka A; Jernajczyk W; Jarema M
    J Psychiatr Res; 2011 Oct; 45(10):1381-6. PubMed ID: 21679968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
    Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
    J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.
    Lambert TJ; Cock N; Alcock SJ; Kelly DL; Conley RR
    Hum Psychopharmacol; 2003 Jul; 18(5):405-11. PubMed ID: 12858330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients.
    Day JC; Wood G; Dewey M; Bentall RP
    Br J Psychiatry; 1995 May; 166(5):650-3. PubMed ID: 7620752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.
    Rudå D; Einarsson G; Matthiassen JB; Correll CU; Jensen KG; Klauber DG; Richard CJ; Andersen ASS; Krøigaard S; Møllegaard Jepsen JR; Fagerlund B; Winge K; Clemmesen LKH; Pagsberg AK; Paulsen RR; Fink-Jensen A
    Child Adolesc Ment Health; 2020 May; 25(2):79-94. PubMed ID: 32307841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
    Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
    BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions.
    Atmaca M; Kuloglu M; Tezcan E
    Int J Impot Res; 2005; 17(2):201-3. PubMed ID: 15284834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics.
    Kikuchi T; Iwamoto K; Sasada K; Aleksic B; Yoshida K; Ozaki N
    Hum Psychopharmacol; 2011; 26(4-5):300-6. PubMed ID: 21695732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.
    Zalsman G; Carmon E; Martin A; Bensason D; Weizman A; Tyano S
    J Child Adolesc Psychopharmacol; 2003; 13(3):319-27. PubMed ID: 14642020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.
    Hofer A; Kemmler G; Eder U; Honeder M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2002 Jan; 63(1):49-53. PubMed ID: 11838626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.